Vascular risk factors, cerebrovascular reactivity, and the default-mode brain network

NeuroImage

Volumn 115, Issue , 2015, Pages 7-16

  Haight, Thaddeus J ^a   Bryan, R Nick ^b   Erus, Guray ^b   Davatzikos, Christos ^b   Jacobs, David R ^c   D'Esposito, Mark ^d   Lewis, Cora E ^e   Launer, Lenore J ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e University of Alabama at Birmingham   (United States)

Author keywords

Alzheimer's disease; Neurophysiology; Vascular risk factors

Indexed keywords

ADULT; ANTERIOR CINGULATE; ARTICLE; BLOOD VESSEL REACTIVITY; BOLD SIGNAL; CARDIOVASCULAR RISK; CEREBROVASCULAR REACTIVITY; DEFAULT MODE NETWORK; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; FRONTAL LOBE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIPPOCAMPUS; HUMAN; HYPERTENSION; MALE; NEUROIMAGING; OCCIPITAL LOBE; PARIETAL LOBE; POSTERIOR CINGULATE; PRECUNEUS; PREHYPERTENSION; PRIORITY JOURNAL; ALGORITHM; BLOOD; BRAIN; BRAIN CIRCULATION; BRAIN DISEASE; BREATH HOLDING; CEREBROVASCULAR DISEASE; CROSS-SECTIONAL STUDY; FOLLOW UP; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; NERVE CELL NETWORK; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; RISK FACTOR; VASCULARIZATION;

OXYGEN;

ALGORITHMS; BRAIN; BRAIN DISEASES; BREATH HOLDING; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DYSLIPIDEMIAS; FEMALE; FOLLOW-UP STUDIES; HIPPOCAMPUS; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE NET; OXYGEN; RISK FACTORS;

EID: 84928888984     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2015.04.039     Document Type: Article

References (74)

1. Alsop D.C., Detre J.A., Grossman M. Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann. Neurol. 2000, 47:93-100.
2. Alsop D.C., Dai W., Grossman M., Detre J.A. Arterial spin labeling blood flow MRI: its role in theearly characterization of Alzheimer's disease. J. Alzheimers Dis. 2010, 20:871-880.
3. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2011, 34(Suppl. 1):S62-S69.
4. Bandettini P.A., Wong E.C. A hypercapnia-based normalization method for improved spatial localization of human brain activation with fMRI. NMR Biomed. 1997, 10:197-203.
5. Beason-Held L.L., Thambisetty M., Deib G., Sojkova J., Landman B.A., Zonderman A.B., Ferrucci L., Kraut M.A., Resnick S.M. Baseline cardiovascular risk predicts subsequent changes in resting brain function. Stroke 2012, 43:1542-1547.
6. Benarroch E.E. Neurovascular unit dysfunction: a vascular component of Alzheimer disease?. Neurology 2007, 68:1730-1732.
7. Bendlin B.B., Carlsson C.M., Gleason C.E., Johnson S.C., Sodhi A., Gallagher C.L., Puglielli L., Engelman C.D., Ries M.L., Xu G., Wharton W., Asthana S. Midlife predictors of Alzheimer's disease. Maturitas 2010, 65:131-137.
8. Bondi M.W., Houston W.S., Eyler L.T., Brown G.G. fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 2005, 64:501-508.
9. Bookheimer S.Y., Strojwas M.H., Cohen M.S., Saunders A.M., Pericak-Vance M.A., Mazziotta J.C., Small G.W. Patterns of brain activation in people at risk for Alzheimer's disease. N. Engl. J. Med. 2000, 343:450-456.
10. Brier M.R., Thomas J.B., Ances B.M. Network dysfunction in Alzheimer's disease: refining the disconnection hypothesis. Brain Connect. 2014, 4:299-311.
11. Buckner R.L., Andrews-Hanna J.R., Schacter D.L. The brain's default network: anatomy, function, and relevance to disease. Ann. N. Y. Acad. Sci. 2008, 1124:1-38.
12. Celone K.A., Calhoun V.D., Dickerson B.C., Atri A., Chua E.F., Miller S.L., DePeau K., Rentz D.M., Selkoe D.J., Blacker D., Albert M.S., Sperling R.A. Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. J. Neurosci. 2006, 26:10222-10231.
13. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., Jones D.W., Materson B.J., Oparil S., Wright J.T., Roccella E.J., Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program Coordinating Committee Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003, 42:1206-1252.
14. Claus J.J., Breteler M.M., Hasan D., Krenning E.P., Bots M.L., Grobbee D.E., Van Swieten J.C., Van Harskamp F., Hofman A. Regional cerebral blood flow and cerebrovascular risk factors in the elderly population. Neurobiol. Aging 1998, 19:57-64.
15. Convit A., Wolf O.T., Tarshish C., de Leon M.J. Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:2019-2022.
16. Dai W., Lopez O.L., Carmichael O.T., Becker J.T., Kuller L.H., Gach H.M. Abnormal regional cerebral blood flow in cognitively normal elderly subjects with hypertension. Stroke 2008, 39:349-354.
17. Dai W., Lopez O.L., Carmichael O.T., Becker J.T., Kuller L.H., Gach H.M. Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology 2009, 250:856-866.
18. Damoiseaux J.S., Greicius M.D. Greater than the sum of its parts: a review of studies combining structural connectivity and resting-state functional connectivity. Brain Struct. Funct. 2009, 213:525-533.
19. Damoiseaux J.S., Prater K.E., Miller B.L., Greicius M.D. Functional connectivity tracks clinical deterioration in Alzheimer's disease. Neurobiol. Aging 2012, 33(828):e819-e830.
20. Daselaar S.M., Prince S.E., Cabeza R. When less means more: deactivations during encoding that predict subsequent memory. NeuroImage 2004, 23:921-927.
21. Dickerson B.C., Salat D.H., Greve D.N., Chua E.F., Rand-Giovannetti E., Rentz D.M., Bertram L., Mullin K., Tanzi R.E., Blacker D., Albert M.S., Sperling R.A. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology 2005, 65:404-411.
22. Dunn C.J., Duffy S.L., Hickie I.B., Lagopoulos J., Lewis S.J., Naismith S.L., Shine J.M. Deficits in episodic memory retrieval reveal impaired default mode network connectivity in amnestic mild cognitive impairment. NeuroImage Clin. 2014, 4:473-480.
23. Duschek S., Schandry R. Reduced brain perfusion and cognitive performance due to constitutional hypotension. Clin. Auton. Res. 2007, 17:69-76.
24. Friedman G.D., Cutter G.R., Donahue R.P., Hughes G.H., Hulley S.B., Jacobs D.R., Liu K., Savage P.J. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J. Clin. Epidemiol. 1988, 41:1105-1116.
25. FSL FSL software for BOLD analysis [cited 2013 June 27 2013]; Available from. http://www.fmrib.ox.ac.uk/fsl/.
26. Gazzaley A., D'Esposito M. BOLD fMRI and cognitive aging. Cognitive Neuroscience of Aging 2005, 107-131. Oxford University Press, New York. R. Cabeza, L. Nyberg, D. Park (Eds.).
27. Glodzik L., Rusinek H., Brys M., Tsui W.H., Switalski R., Mosconi L., Mistur R., Pirraglia E., de Santi S., Li Y., Goldowsky A., de Leon M.J. Framingham cardiovascular risk profile correlates with impaired hippocampal and cortical vasoreactivity to hypercapnia. J. Cereb. Blood Flow Metab. 2011, 31:671-679.
28. Goldszal A.F., Davatzikos C., Pham D.L., Yan M.X., Bryan R.N., Resnick S.M. An image-processing system for qualitative and quantitative volumetric analysis of brain images. J. Comput. Assist. Tomogr. 1998, 22:827-837.
29. Greicius M.D., Srivastava G., Reiss A.L., Menon V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:4637-4642.
30. Handwerker D.A., Gazzaley A., Inglis B.A., D'Esposito M. Reducing vascular variability of fMRI data across aging populations using a breathholding task. Hum. Brain Mapp. 2007, 28:846-859.
31. Hedden T., Gabrieli J.D. Insights into the ageing mind: a view from cognitive neuroscience. Nat. Rev. Neurosci. 2004, 5:87-96.
32. Hedden T., Van Dijk K., Becker A., Mehta A., Sperling R., Johnson K., Buckner R.L. Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. J. Neurosci. 2009, 29:12686-12694.
33. Ishii K., Soma T., Kono A.K., Sofue K., Miyamoto N., Yoshikawa T., Mori E., Murase K. Comparison of regional brain volume and glucose metabolism between patients with mild dementia with lewy bodies and those with mild Alzheimer's disease. J. Nucl. Med. 2007, 48:704-711.
34. Jack C.R., Knopman D.S., Jagust W.J., Shaw L.M., Aisen P.S., Weiner M.W., Petersen R.C., Trojanowski J.Q. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010, 9:119-128.
35. Jack C.R., Knopman D.S., Jagust W.J., Petersen R.C., Weiner M.W., Aisen P.S., Shaw L.M., Vemuri P., Wiste H.J., Weigand S.D., Lesnick T.G., Pankratz V.S., Donohue M.C., Trojanowski J.Q. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013, 12:207-216.
36. Imaging the Aging Brain 2009, Oxford University Press, New York. W.J. Jagust, M. D'Esposito (Eds.).
37. Jennings J.R., Muldoon M.F., Ryan C., Price J.C., Greer P., Sutton-Tyrrell K., van der Veen F.M., Meltzer C.C. Reduced cerebral blood flow response and compensation among patients with untreated hypertension. Neurology 2005, 64:1358-1365.
38. Johnson N.A., Jahng G.H., Weiner M.W., Miller B.L., Chui H.C., Jagust W.J., Gorno-Tempini M.L., Schuff N. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 2005, 234:851-859.
39. Kabani N.J., Collins D.L., Evans A.C. A 3D neuroanatomical atlas. Fourth International Conference on Functional Mapping of the Human Brain 1998.
40. Kastrup A., Kruger G., Glover G.H., Neumann-Haefelin T., Moseley M.E. Regional variability of cerebral blood oxygenation response to hypercapnia. NeuroImage 1999, 10:675-681.
41. 2 and breath holding. Magn. Reson. Imaging 2001, 19:13-20.
42. Kivipelto M., Helkala E.L., Hanninen T., Laakso M.P., Hallikainen M., Alhainen K., Soininen H., Tuomilehto J., Nissinen A. Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology 2001, 56:1683-1689.
43. Lao Z., Shen D., Liu D., Jawad A.F., Melhem E.R., Launer L.J., Bryan R.N., Davatzikos C. Computer-assisted segmentation of white matter lesions in 3D MR images using support vector machine. Acad. Radiol. 2008, 15:300-313.
44. Last D., Alsop D.C., Abduljalil A.M., Marquis R.P., de Bazelaire C., Hu K., Cavallerano J., Novak V. Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity. Diabetes Care 2007, 30:1193-1199.
45. Launer L.J., Masaki K., Petrovitch H., Foley D., Havlik R.J. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA 1995, 274:1846-1851.
46. Launer L.J., Ross G.W., Petrovitch H., Masaki K., Foley D., White L.R., Havlik R.J. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol. Aging 2000, 21:49-55.
47. Launer L.J., Lewis C.E., Schreiner P.J., Sidney S., Battapady H., Jacobs D.R., Lim K.O., D'Esposito M., Zhang Q., Reis J., Davatzikos C., Bryan R.N. Vascular factors and multiple measures of early brain health: CARDIA Brain MRI Study. PLoS One 2015, 10(3):e0122138.
48. Littell R.C., Milliken G.A., Stroup W.W., Wolfinger R.D. SAS System for Mixed Models 1996, SAS Institute, Cary, NC.
49. Mayda A.B., Westphal A., Carter C.S., DeCarli C. Late life cognitive control deficits are accentuated by white matter disease burden. Brain 2011, 134:1673-1683.
50. Miller S.L., Celone K., DePeau K., Diamond E., Dickerson B.C., Rentz D., Pihlajamaki M., Sperling R.A. Age-related memory impairment associated with loss of parietal deactivation but preserved hippocampal activation. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:2181-2186.
51. Miller M., Stone N.J., Ballantyne C., Bittner V., Criqui M.H., Ginsberg H.N., Goldberg A.C., Howard W.J., Jacobson M.S., Kris-Etherton P.M., Lennie T.A., Levi M., Mazzone T., Pennathur S., American Heart Association Clinical Lipidology, Thrombosis, and Prevention Committee of the Council on Nutrition, Physical Activity, and Metabolism, Council on Arteriosclerosis, Thrombosis, and Vascular Biology, Council on Cardiovascular Nursing, Council on the Kidney in Cardiovascular Disease Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2011, 123:2292-2333.
52. Muller M., van der Graaf Y., Visseren F.L., Mali W.P., Geerlings M.I., Group S.S. Hypertension and longitudinal changes in cerebral blood flow: the SMART-MR study. Ann. Neurol. 2012, 71:825-833.
53. Murphy K., Harris A.D., Wise R.G. Robustly measuring vascular reactivity differences with breath-hold: normalising stimulus-evoked and resting state BOLD fMRI data. NeuroImage 2011, 54:369-379.
54. Novak V. Cognition and hemodynamics. Curr. Cardiovasc. Risk Rep. 2012, 6:380-396.
55. Papma J., den Heijer T., de Koning I., Mattace-Raso F., van der Lugt A., van der Lijn F., van Swieten J., Koudstaal P., Smits M., Prins N. The influence of cerebral small vessel disease on default mode network deactivation in mild cognitive impairment. NeuroImage Clin. 2013, 2:33-42.
56. Pillai J.J., Milkulis D.J. Cerebrovascular reactivity mapping: an evolving standard for clinical functional imaging. AJNR 2015, 36:7-13.
57. Raichle M.E., MacLeod A.M., Snyder A.Z., Powers W.J., Gusnard D.A., Shulman G.L. A default mode of brain function. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:676-682.
58. Resnick S.M., Pham D.L., Kraut M.A., Zonderman A.B., Davatzikos C. Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain. J. Neurosci. 2003, 23:3295-3301.
59. Riecker A., Grodd W., Klose U., Schulz J.B., Groschel K., Erb M., Ackermann H., Kastrup A. Relation between regional functional MRI activation and vascular reactivity to carbon dioxide during normal aging. J. Cereb. Blood Flow Metab. 2003, 23:565-573.
60. Roberts R.O., Knopman D.S., Przybelski S.A., Mielke M.M., Kantarci K., Preboske G.M., Senjem M.L., Pankratz V.S., Geda Y.E., Boeve B.F., Ivnik R.J., Rocca W.A., Petersen R.C., Jack C.R. Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology 2014, 82:1132-1141.
61. Rossini P.M., Altamura C., Ferretti A., Vernieri F., Zappasodi F., Caulo M., Pizzella V., Del Gratta C., Romani G.L., Tecchio F. Does cerebrovascular disease affect the coupling between neuronal activity and local haemodynamics?. Brain 2004, 127:99-110.
62. Schuff N., Matsumoto S., Kmiecik J., Studholme C., Du A., Ezekiel F., Miller B.L., Kramer J.H., Jagust W.J., Chui H.C., Weiner M.W. Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging. Alzheimers Dement. 2009, 5:454-462.
63. Sheline Y.I., Raichle M.E. Resting state functional connectivity in preclinical Alzheimer's disease. Biol. Psychiatry 2013, 74:340-347.
64. Shen D., Davatzikos C. HAMMER: hierarchical attribute matching mechanism for elastic registration. IEEE Trans. Med. Imaging 2002, 21:1421-1439.
65. Silvestrini M., Vernieri F., Pasqualetti P., Matteis M., Passarelli F., Troisi E., Caltagirone C. Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. JAMA 2000, 283:2122-2127.
66. Sorond F.A., Galica A., Serrador J.M., Kiely D.K., Iloputaife I., Cupples L.A., Lipsitz L.A. Cerebrovascular hemodynamics, gait, and falls in an elderly population: MOBILIZE Boston Study. Neurology 2010, 74:1627-1633.
67. Sperling R. Functional MRI studies of associative encoding in normal aging, mild cognitive impairment, and Alzheimer's disease. Ann. N. Y. Acad. Sci. 2007, 1097:146-155.
68. Stefani A., Sancesario G., Pierantozzi M., Leone G., Galati S., Hainsworth A.H., Diomedi M. CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer's and mixed dementia. J. Neurol. Sci. 2009, 283:109-115.
69. Thompson P.M., Mega M.S., Woods R.P., Zoumalan C.I., Lindshield C.J., Blanton R.E., Moussai J., Holmes C.J., Cummings J.L., Toga A.W. Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. Cereb. Cortex 2001, 11:1-16.
70. Vernieri F., Pasqualetti P., Passarelli F., Rossini P.M., Silvestrini M. Outcome of carotid artery occlusion is predicted by cerebrovascular reactivity. Stroke 1999, 30:593-598.
71. Wang Z., Aguirre G., Rao H., Wang J., Fernández-Seara M., Childress A., Detre J. Empirical optimization of of ASL data analysis using an ASL data processing toolbox: ALS tbx. Magn. Reson. Imaging 2008, 26:261-269.
72. Wu W., Brickman A.M., Luchsinger J., Ferrazzano P., Pichiule P., Yoshita M., Brown T., DeCarli C., Barnes C.A., Mayeux R., Vannucci S.J., Small S.A. The brain in the age of old: the hippocampal formation is targeted differentially by diseases of late life. Ann. Neurol. 2008, 64:698-706.
73. Yakushev I., Landvogt C., Buchholz H.G., Fellgiebel A., Hammers A., Scheurich A., Schmidtmann I., Gerhard A., Schreckenberger M., Bartenstein P. Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18. Psychiatry Res. 2008, 164:143-153.
74. Zacharaki E.I., Kanterakis S., Bryan R.N., Davatzikos C. Measuring brain lesion progression with a supervised tissue classification system. Med. Image Comput. Comput. Assist. Interv. 2008, 11:620-627.